Our previous study reported increased levels of both angiopoietin-1/-2 and VEGF in BRCA-related breast tumors, highlighting their contribution to vascular remodeling in patients harboring BRCA1/2 mutations [17]. Here, BRCA1 is linked to breast neoplasm.